We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+6.93%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$262M
AUM Growth
+$52.1M
(+25%)
Cap. Flow
+$36.5M
Cap. Flow
% of AUM
13.94%
Top 10 Holdings %
Top 10 Hldgs %
72.18%
Holding
59
New
13
Increased
28
Reduced
6
Closed
5
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$15.9M |
| 2 |
State Street SPDR S&P Dividend ETF
SDY
|
+$3.49M |
| 3 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$3.38M |
| 4 |
Alerian MLP ETF
AMLP
|
+$2.45M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$2.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$697K |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$583K |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$397K |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$392K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.97% |
| 2 | Healthcare | 1.8% |
| 3 | Materials | 0.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P Dividend ETF
SDY
$21.4B
| $43.5M | 16.61% |
598,326
+48,587
| +9% | +$3.49M |
2013 Q2
2 quarters
|
|
|
2
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $43M | 16.44% |
2,593,400
+212,690
| +9% | +$3.38M |
2013 Q2
2 quarters
|
|
|
3
Vanguard FTSE Europe ETF
VGK
$29.7B
| $30.7M | 11.74% |
522,548
+39,569
| +8% | +$2.23M |
2013 Q2
2 quarters
|
|
|
4
Alerian MLP ETF
AMLP
$12.5B
| $17.4M | 6.65% |
195,595
+27,883
| +17% | +$2.45M |
2013 Q2
2 quarters
|
|
|
RCPT
5
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $17.2M | 6.58% |
+594,142
| New | +$15.9M |
2013 Q4
0 quarters
|
|
|
6
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $10.4M | 3.96% |
251,757
-14,147
| -5% | -$583K |
2013 Q2
2 quarters
|
|
7
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $8.13M | 3.11% |
455,046
+16,766
| +4% | +$284K |
2013 Q2
2 quarters
|
|
8
iShares MSCI Japan ETF
EWJ
$23.2B
| $7.05M | 2.7% |
145,284
+31,555
| +28% | +$1.5M |
2013 Q2
2 quarters
|
|
9
iShares MSCI Pacific ex Japan ETF
EPP
$2.21B
| $6.46M | 2.47% |
138,277
+27,838
| +25% | +$1.34M |
2013 Q2
2 quarters
|
|
10
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| $5.03M | 1.92% |
90,660
+5,443
| +6% | +$291K |
2013 Q2
2 quarters
|
|
11
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.65B
| $5M | 1.91% |
255,545
+21,275
| +9% | +$396K |
2013 Q2
2 quarters
|
|
12
iShares MSCI Canada ETF
EWC
$7.28B
| $4.95M | 1.89% |
169,668
+10,735
| +7% | +$311K |
2013 Q2
2 quarters
|
|
13
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.2B
| $4.7M | 1.8% |
140,558
+8,132
| +6% | +$259K |
2013 Q2
2 quarters
|
|
14
Vanguard Morningstar Mid-Cap ETF
VO
$107B
| $4.68M | 1.79% |
170,136
+19,812
| +13% | +$528K |
2013 Q2
2 quarters
|
|
15
iShares Europe ETF
IEV
$1.6B
| $4.57M | 1.74% |
96,197
+1,700
| +2% | +$77.4K |
2013 Q2
2 quarters
|
|
16
State Street Financial Select Sector SPDR ETF
XLF
$51.4B
| $4.32M | 1.65% |
224,905
+29,131
| +15% | +$536K |
2013 Q2
2 quarters
|
|
17
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.5B
| $4.14M | 1.58% |
96,447
+8,894
| +10% | +$375K |
2013 Q2
2 quarters
|
|
18
State Street Industrial Select Sector SPDR ETF
XLI
$30.6B
| $4.08M | 1.56% |
78,134
+3,363
| +4% | +$165K |
2013 Q2
2 quarters
|
|
19
State Street Energy Select Sector SPDR ETF
XLE
$42.8B
| $4.07M | 1.55% |
91,904
+5,674
| +7% | +$244K |
2013 Q2
2 quarters
|
|
20
WisdomTree Japan Hedged Equity Fund
DXJ
$2.35B
| $4.03M | 1.54% |
237,855
+1,665
| +0.7% | +$27K |
2013 Q2
2 quarters
|
|
|
21
iShares MSCI Emerging Markets ETF
EEM
$29.6B
| $3.72M | 1.42% |
89,025
-9,366
| -10% | -$392K |
2013 Q2
2 quarters
|
|
22
Vanguard FTSE All-World ex-US ETF
VEU
$67.4B
| $2.86M | 1.09% |
56,332
+5,812
| +12% | +$289K |
2013 Q2
2 quarters
|
|
23
Halozyme
HALO
$13.8B
| $2.47M | 0.95% |
165,000
| – | – |
2013 Q2
2 quarters
|
|
24
iShares US Financials ETF
IYF
$3.84B
| $1.98M | 0.76% |
49,348
-1,144
| -2% | -$44.1K |
2013 Q2
2 quarters
|
|
25
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.75B
| $1.74M | 0.66% |
28,806
| – | – |
2013 Q2
2 quarters
|
|
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Callan Capital held 59 positions worth $262M, up 25% from $210M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Callan Capital deployed $36.5M of net new capital in Q4 2013, opening 13 new positions and adding to 28 existing holdings. Its largest new stake was RECEPTOS INC COM STK (DE): 594,142 shares worth $17.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, down from 98% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was PIMCO Active Bond Exchange-Traded Fund, an estimated $697K trimmed.
- Callan Capital's largest Q4 2013 buy was RECEPTOS INC COM STK (DE): 594,142 shares worth $17.2M.
- Callan Capital added most to State Street SPDR S&P Dividend ETF in Q4 2013, an estimated $3.49M increase.
- Callan Capital's biggest Q4 2013 reduction was PIMCO Active Bond Exchange-Traded Fund, cutting an estimated $697K.
- Callan Capital fully exited Vanguard Short-Term Bond ETF in Q4 2013, selling an estimated $504K.
- Callan Capital's ten largest holdings make up 72% of its $262M portfolio in Q4 2013.
- Callan Capital opened 13 new positions and closed 5 in Q4 2013.
- Callan Capital's portfolio value rose 25% quarter-over-quarter to $262M.
Based on Callan Capital's 13F filing for Q4 2013, filed 12 Feb 2014.